NDRA
ENDRA Life Sciences Inc. (NASDAQ)
Healthcare — Diagnostics & Research
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
Price History
Fundamentals
| Market Cap | $6.40M |
| P/E Ratio (TTM) | - |
| Forward P/E | -1.66 |
| EPS (TTM) | $-8.16 |
| Dividend Yield | - |
| Profit Margin | - |
| Revenue Growth | - |
| ROE | -412.60% |
| Debt/Equity | 25.81 |
| Recommendation | None |
| Analyst Target | $25.00 |
| Analysts | 1 |
| Indexes | NASDAQ |
Technical Indicators
| RSI (14) | 56.9 |
| Beta | -0.04 |
| SMA 20 | - |
| SMA 40 | - |
| 52-Week High | $11.96 |
| 52-Week Low | $2.96 |
| 50-Day Avg | $5.05 |
| 200-Day Avg | $4.93 |
| Avg Volume | 30.9K |
| Volume | 25.5K |
Performance Analysis
BULLISHNDRA shows predominantly bullish signals based on its fundamentals and technicals.
Recent News
Last updated: Jul 02, 2026 13:22 UTC
Back to Screener Export Report